Financial advice

Discussion in 'Neurocrine' started by anonymous, Apr 30, 2019 at 4:11 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Word of advice from a rep that has worked at several start ups. Take some chips off the table and don’t keep rolling the dice. It’s ok to cash in options and espp and switch it to a safer investment, pay off a car or buy a new fucking boat or something.

    I have seen people lose a shit ton of money all due to one article or bad press. Take some money off the table and leave the rest of your rsus as the gamble.

    Good luck!
     

  2. anonymous

    anonymous Guest

    i meant rsus not options above.
     
  3. anonymous

    anonymous Guest

    Good advice. It's hard to know if 70 /75 is the bottom or if the slide will continue.
     
  4. anonymous

    anonymous Guest

    Plenty of buyout talk recently
     
  5. anonymous

    anonymous Guest

    I don't think a buy out is close. Try searching for insider trades. Someone is selling off bigly
     
  6. anonymous

    anonymous Guest

    Bozo?
     
  7. anonymous

    anonymous Guest

    Yea, kind of gimpy with fur like a chimp
     
  8. anonymous

    anonymous Guest

    The end is close (buyout) when they start looking at call averages and other metrics that are not directly related to sales success. A lot of pressure being put on the middle managers about call activity and implementation from the field. When a company starts diving in deep in this...it’s never a good thing. Welcome to the “new normal,” people. Culture Sulture. Waaa waaa whaaaa
     
  9. anonymous

    anonymous Guest

    Over the last quarter, insiders sold 153,518 shares valued at $14,627,606.
     
  10. anonymous

    anonymous Guest

    With the bump in stock price, you may want to cash your options. You don't want to wait til q1 or even worse q2 results with your d___ in your hand! cash out while you can
     
  11. anonymous

    anonymous Guest

    Why worry?
    Call rate
    Pharma supply chain
    Hydroxychloroquine QT / TdP
    Delayed FDA reviews
    DoJ
     
  12. anonymous

    anonymous Guest

    Deja vu all over again (2018) - Sep 24 at $123 to Dec 24 at $68. Cash in, pay off your mortgage
     
  13. anonymous

    anonymous Guest

     
  14. anonymous

    anonymous Guest

    Fuck you! who asked for your advice? are you a financial planner??
     
  15. anonymous

    anonymous Guest

    Jokes on you. We're only dropping by $10 a month!
     
  16. anonymous

    anonymous Guest

    On 02/08/2021 CEO sold 12,888 share at average price $116.26/share (= $1.5 million).
     
  17. anonymous

    anonymous Guest

    Check out our share price! Bang, zoom, to the moon, Alice!

    (until 4:30 at least)
     
  18. anonymous

    anonymous Guest

    Short selling isn't for most investors. Remember it's illegal to trade on "material nonpublic information" unless you're a US Senator